66. IgA nephropathy Clinical trials / Disease details
Clinical trials : 275 / Drugs : 258 - (DrugBank : 82) / Drug target genes : 36 - Drug target pathways : 140
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2100042331 | 2021-03-01 | 2021-01-19 | Effect evaluation and related mechanism research on different stages of IgA nephropathy treated by supplementing Qi, nourishing Yin and removing blood stasis | Effect evaluation and related mechanism research on different stages of IgA nephropathy treated by supplementing Qi, nourishing Yin and removing blood stasis | IgAN | treatment group:Add or subtract Shenqi Dihuang soup;treatment group:Remove blood stasis and remove cloudy drink;matched group:Nil;matched group:Nil; | Zhejiang Provincal Hospital of Traditional Chinese Medicine | NULL | Recruiting | 18 | 75 | Both | treatment group:35;treatment group:60;matched group:35;matched group:60; | China | |
| 2 | ITMCTR2100004291 | 2021-03-01 | 2021-01-19 | Effect evaluation and related mechanism research on different stages of IgA nephropathy treated by supplementing Qi, nourishing Yin and removing blood stasis | Effect evaluation and related mechanism research on different stages of IgA nephropathy treated by supplementing Qi, nourishing Yin and removing blood stasis | IgAN | treatment group:Add or subtract Shenqi Dihuang soup;matched group:Nil;treatment group:Remove blood stasis and remove cloudy drink;matched group:Nil;;01000200 | Zhejiang Provincal Hospital of Traditional Chinese Medicine | NULL | Recruiting | 18 | 75 | Both | treatment group:35;matched group:60;treatment group:60;matched group:35; | China | |
| 3 | ChiCTR1900022100 | 2019-04-01 | 2019-03-25 | Evaluation of clinical efficacy of Modified Huangqi Chifeng Decoction in treating IgA Nephropathy proteinuia based on Chinese medicine pathogenesis of deficiency-wind-stasis -toxin” | Evaluation of clinical efficacy of Modified Huangqi Chifeng Decoction in treating IgA Nephropathy proteinuia based on Chinese medicine pathogenesis of deficiency-wind-stasis -toxin” | IgA nephropathy | Placebo Group:Placebo+telmisartan;Experimental group:Flavoured huangqi chifeng granules+telmisartan; | Xiyuan Hospital, China Academy of Chinese Medical Sciences | NULL | Recruiting | Both | Placebo Group:40;Experimental group:40; | N/A | China |